ファストメルト錠の世界市場レポート 2025年

ファストメルト錠市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）8.1%で73億5,000万米ドルに成長します。予測期間中の成長は、嚥下障害の有病率の上昇、一般用医薬品（OTC）への嗜好の高まり、eコマースの普及拡大、経口溶解薬の需要増加、ヘルスケアインフラの拡大などに起因すると考えられます。予測期間に予想される主な動向には、技術の進歩、革新的な製剤技術、ナノテクノロジーの統合、植物由来の賦形剤へのシフト、スマート・ドラッグデリバリー・システムの開発などがあります。

心臓発作の発生率の増加が、今後数年間のファストメルト錠市場の成長を牽引すると予想されます。心臓発作は、心筋への血流が阻害されたときに発生するが、多くの場合、冠動脈内の血栓やプラークの蓄積が原因です。心臓発作の発生率が上昇しているのは、コレステロール値の上昇や動脈内のプラーク形成を助長する加工食品の消費量が増加しているためと考えられます。ファストメルト錠は迅速な薬物吸収を可能にし、心臓発作時のダメージを軽減するアスピリンやニトログリセリンのような必須薬剤の迅速なデリバリーを促進します。この迅速な作用は、血流を回復させ、患者の予後を改善し、重篤な合併症のリスクを低下させる。例えば、2024年1月に英国心臓財団が発表した報告書によると、2022年にはイングランドで3万9,000人以上が心臓発作、冠動脈性心疾患、脳卒中などの心血管系疾患で早死にし、1週間平均で約750人が死亡しました。これは過去最高の数字です。このように、心臓発作の発生率の上昇がファストメルト錠市場の成長に寄与しています。

ファストメルト錠市場の主要企業は、患者の利便性を高め、薬物の吸収を促進する速溶錠などの革新的な製品の開発に注力しています。速溶錠（RDT）は水を必要とせず、口の中で素早く溶けるように設計されています。例えば、米国を拠点とする臨床段階の製薬会社メルト・ファーマシューティカルズは2022年12月、効率的な鎮静を目的とした高度な速溶錠製剤「メルト300」を発表しました。この錠剤は、3mgのミダゾラムと50mgのケタミンを配合し、急速に溶けるため、静脈内投与を必要とせず、迅速な発現と効果的な鎮静を実現します。Melt 300は、注射針を使用しない、患者に優しい鎮静オプションに対する需要の高まりに対応し、臨床ワークフローを最適化すると同時に、手技の快適性を向上させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ファストメルト錠PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のファストメルト錠市場：成長率分析
• 世界のファストメルト錠市場の実績：規模と成長, 2019-2024
• 世界のファストメルト錠市場の予測：規模と成長, 2024-2029, 2034F
• 世界ファストメルト錠総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のファストメルト錠市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗精神病薬
• 抗てんかん薬
• 中枢神経系（CNS）刺激薬
• 抗不安薬
• 抗パーキンソン病薬
• 降圧剤
• 非ステロイド性抗炎症薬（NSAID）
• 抗アレルギー薬
• プロトンポンプ阻害剤
• その他のタイプ
• 世界のファストメルト錠市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• アレルギーおよび呼吸器疾患
• 神経疾患
• 胃腸障害
• 心血管疾患
• その他の適応症
• 世界のファストメルト錠市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 舌下
• 頬側
• チュアブル
• 世界のファストメルト錠市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 成人用
• 小児科
• 老年医学
• 世界のファストメルト錠市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• ドラッグストア
• オンライン薬局
• 世界のファストメルト錠市場抗精神病薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非定型抗精神病薬
• 定型抗精神病薬
• 世界のファストメルト錠市場抗てんかん薬によるサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ナトリウムチャネル遮断薬
• ガンマアミノ酪酸（GABA）類似体
• α-アミノ-3-ヒドロキシ-5-メチル-4-イソキサゾールプロピオン酸（AMPA）受容体拮抗薬
• 炭酸脱水酵素阻害剤
• 世界のファストメルト錠市場中枢神経系（CNS）刺激薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アンフェタミン
• メチルフェニデート
• モダフィニル
• キサンチン誘導体
• 世界のファストメルト錠市場抗不安薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベンゾジアゼピン
• アザピロン
• バルビツール酸
• 抗ヒスタミン薬
• 世界のファストメルト錠市場抗パーキンソン病薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドーパミン作動薬
• モノアミン酸化酵素B（MAO-B）阻害剤
• カテコール-O-メチルトランスフェラーゼ（COMT）阻害剤
• 抗コリン薬
• 世界のファストメルト錠市場、降圧剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベータ遮断薬
• カルシウムチャネル遮断薬
• アンジオテンシン変換酵素（ACE）阻害剤
• アンジオテンシンII受容体拮抗薬（ARB）
• 利尿剤
• 世界のファストメルト錠市場非ステロイド性抗炎症薬（NSAID）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シクロオキシゲナーゼ-1（COX-1）阻害剤
• シクロオキシゲナーゼ-2（COX-2）阻害剤
• 世界のファストメルト錠市場抗アレルギー薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• ロイコトリエン受容体拮抗薬
• 肥満細胞安定剤
• コルチコステロイド
• 世界のファストメルト錠市場プロトンポンプ阻害剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• オメプラゾール
• エソメプラゾール
• ランソプラゾール
• パントプラゾール
• 世界のファストメルト錠市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 制吐剤
• 抗うつ薬
• 筋弛緩剤
• 鎮痛剤

第7章 地域別・国別分析

• 世界のファストメルト錠市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のファストメルト錠市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ファストメルト錠市場：競合情勢
• ファストメルト錠市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Fuji Chemical Industries Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sun Pharmaceutical Industries Ltd
• Catalent Inc.
• Aurobindo Pharma Limited
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• Centrient Pharmaceuticals B.V.
• Lannett Company Inc.
• Unichem Laboratories Ltd.
• SPI Pharma Inc.
• Windmill Health Products LLC
• The Procter & Gamble Company
• Perrigo Company plc
• Melt Pharmaceuticals Inc.
• Imodium
• Calpol

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ファストメルト錠市場2029：新たな機会を提供する国
• ファストメルト錠市場2029：新たな機会を提供するセグメント
• ファストメルト錠市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Fast melt tablets are oral dosage forms designed to dissolve quickly in the mouth without the need for water, offering a convenient alternative for patients who have difficulty swallowing traditional tablets. These tablets rapidly disintegrate, typically within seconds, upon contact with saliva. Fast melt technology is particularly useful for pediatric, geriatric, and travel-friendly medications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of fast melt tablets include antipsychotics, antiepileptics, central nervous system (CNS) stimulants, anxiolytics, anti-parkinsonian drugs, antihypertensives, non-steroidal anti-inflammatory drugs (NSAIDs), anti-allergy drugs, proton pump inhibitors, and other categories. Antipsychotics, for example, help balance brain chemicals to manage conditions such as schizophrenia and bipolar disorder, often available in fast-melt form to improve patient adherence. These tablets are used for a range of indications, such as pain management, allergy and respiratory disorders, neurological conditions, gastrointestinal issues, and cardiovascular diseases. They come in various dosage forms, including oral, sublingual, buccal, and chewable, and are used by different age groups, including adults, children, and the elderly. These products are distributed through hospital pharmacies, retail pharmacies, drug stores, and online platforms.

The fast melt tablets market research report is one of a series of new reports from The Business Research Company that provides fast melt tablets market statistics, including the fast melt tablets industry global market size, regional shares, competitors with the fast melt tablets market share, detailed fast melt tablets market segments, market trends, and opportunities, and any further data you may need to thrive in the fast melt tablets industry. This fast melt tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fast melt tablets market size has grown strongly in recent years. It will grow from$4.96 billion in 2024 to $5.38 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the rise in the geriatric population, an increase in chronic diseases, the growth in self-medication trends, the expansion of the pharmaceutical sector, and an increase in disposable income.

The fast melt tablets market size is expected to see strong growth in the next few years. It will grow to$7.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the rising prevalence of dysphagia, a growing preference for over-the-counter (OTC) drugs, increasing e-commerce penetration, rising demand for oral dissolving drugs, and the expansion of healthcare infrastructure. Major trends expected in the forecast period include technological advancements, innovative formulation techniques, the integration of nanotechnology, a shift towards plant-based excipients, and the development of smart drug delivery systems.

The increasing incidence of heart attacks is expected to drive the growth of the fast melt tablets market in the coming years. A heart attack occurs when blood flow to the heart muscle is obstructed, often due to a blood clot or plaque buildup in the coronary arteries. The rising incidence of heart attacks can be attributed to higher consumption of processed foods, which contributes to elevated cholesterol levels and plaque formation in the arteries. Fast melt tablets enable rapid drug absorption, facilitating the swift delivery of essential medications such as aspirin or nitroglycerin to mitigate damage during a heart attack. This quick action helps restore blood flow, improving patient outcomes and lowering the risk of severe complications. For example, according to a report by the British Heart Foundation in January 2024, over 39,000 people in England died prematurely from cardiovascular conditions such as heart attacks, coronary heart disease, and stroke in 2022, averaging around 750 deaths per week. This represents the highest recorded figure. As such, the rising heart attack incidence is contributing to the growth of the fast melt tablets market.

Leading companies in the fast melt tablets market are focusing on developing innovative products, such as rapidly dissolving tablets that enhance patient convenience and accelerate drug absorption. Rapidly dissolving tablets (RDTs) are designed to dissolve quickly in the mouth without the need for water. For instance, in December 2022, Melt Pharmaceuticals, a US-based clinical-stage pharmaceutical company, introduced Melt 300, an advanced fast-melting tablet formulation aimed at efficient sedation. This tablet combines 3 mg of midazolam and 50 mg of ketamine, dissolving rapidly for quick onset and effective sedation without requiring intravenous administration. Targeting the growing demand for needle-free, patient-friendly sedation options, Melt 300 improves procedural comfort while optimizing clinical workflows.

In September 2023, Melt Pharmaceuticals, Inc., a US-based clinical-stage pharmaceutical company, entered into a licensing agreement with Catalent Inc. Under this partnership, Melt will utilize Catalent's proprietary Zydis orally disintegrating tablet technology to develop a sublingual, needle-free, and opioid-free formulation that combines midazolam and ketamine. Catalent Inc., a US-based company specializing in drug development and delivery solutions for biologics, gene therapies, and oral, inhalation, and injectable drug delivery technologies, will support this collaboration.

Major players in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, and Akina Inc.

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fast melt tablets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fast melt tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fast melt tablets market consists of sales of orally disintegrating tablets (ODTs), prescription medications, and over-the-counter (OTC) medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fast Melt Tablets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fast melt tablets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fast melt tablets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fast melt tablets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Anti Psychotics; Anti Epileptics; Central Nervous System (CNS) Stimulants; Anxiolytics; Anti Parkinsonian Drugs; Anti Hypertensive; Non-Steroidal Anti-Inflammatory Drugs (NSAIDS); Anti Allergy Drugs; Proton Pump Inhibitors; Other Types
• 2) By Indication: Pain Management; Allergy And Respiratory Disorders; Neurological Disorders; Gastrointestinal Disorders; Cardiovascular Disorders; Other Indications
• 3) By Dosage Form: Oral; Sublingual; Buccal; Chewable
• 4) By Age Group: Adult; Pediatrics; Geriatrics
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Online Pharmacies
• Subsegments:
• 1) By Anti Psychotics: Atypical Antipsychotics; Typical Antipsychotics
• 2) By Anti Epileptics: Sodium Channel Blockers; Gamma-Aminobutyric Acid (GABA) Analogs; Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists; Carbonic Anhydrase Inhibitors
• 3) By Central Nervous System (CNS) Stimulants: Amphetamines; Methylphenidate; Modafinil; Xanthine Derivatives
• 4) By Anxiolytics: Benzodiazepines; Azapirones; Barbiturates; Antihistamines
• 5) By Anti Parkinsonian Drugs: Dopamine Agonists; Monoamine Oxidase-B (MAO-B) Inhibitors; Catechol-O-Methyltransferase (COMT) Inhibitors; Anticholinergics
• 6) By Anti Hypertensive: Beta Blockers; Calcium Channel Blockers; Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Diuretics
• 7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors; Cyclooxygenase-2 (COX-2) Inhibitors
• 8) By Anti Allergy Drugs: Antihistamines; Leukotriene Receptor Antagonists; Mast Cell Stabilizers; Corticosteroids
• 9) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole
• 10) By Other Types: Antiemetics; Antidepressants; Muscle Relaxants; Analgesics
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Fuji Chemical Industries Co. Ltd.; Teva Pharmaceutical Industries Ltd.; Church & Dwight Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fast Melt Tablets Market Characteristics

3. Fast Melt Tablets Market Trends And Strategies

4. Fast Melt Tablets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Fast Melt Tablets Growth Analysis And Strategic Analysis Framework

• 5.1. Global Fast Melt Tablets PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Fast Melt Tablets Market Growth Rate Analysis
• 5.4. Global Fast Melt Tablets Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Fast Melt Tablets Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Fast Melt Tablets Total Addressable Market (TAM)

6. Fast Melt Tablets Market Segmentation

• 6.1. Global Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti Psychotics
• Anti Epileptics
• Central Nervous System (CNS) Stimulants
• Anxiolytics
• Anti Parkinsonian Drugs
• Anti Hypertensive
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
• Anti Allergy Drugs
• Proton Pump Inhibitors
• Other Types
• 6.2. Global Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Allergy And Respiratory Disorders
• Neurological Disorders
• Gastrointestinal Disorders
• Cardiovascular Disorders
• Other Indications
• 6.3. Global Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Sublingual
• Buccal
• Chewable
• 6.4. Global Fast Melt Tablets Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult
• Pediatrics
• Geriatrics
• 6.5. Global Fast Melt Tablets Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• 6.6. Global Fast Melt Tablets Market, Sub-Segmentation Of Anti Psychotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atypical Antipsychotics
• Typical Antipsychotics
• 6.7. Global Fast Melt Tablets Market, Sub-Segmentation Of By Anti Epileptics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sodium Channel Blockers
• Gamma-Aminobutyric Acid (GABA) Analogs
• Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists
• Carbonic Anhydrase Inhibitors
• 6.8. Global Fast Melt Tablets Market, Sub-Segmentation Of Central Nervous System (CNS) Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amphetamines
• Methylphenidate
• Modafinil
• Xanthine Derivatives
• 6.9. Global Fast Melt Tablets Market, Sub-Segmentation Of Anxiolytics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzodiazepines
• Azapirones
• Barbiturates
• Antihistamines
• 6.10. Global Fast Melt Tablets Market, Sub-Segmentation Of Anti Parkinsonian Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dopamine Agonists
• Monoamine Oxidase-B (MAO-B) Inhibitors
• Catechol-O-Methyltransferase (COMT) Inhibitors
• Anticholinergics
• 6.11. Global Fast Melt Tablets Market, Sub-Segmentation Of Anti Hypertensive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta Blockers
• Calcium Channel Blockers
• Angiotensin-Converting Enzyme (ACE) Inhibitors
• Angiotensin II Receptor Blockers (ARBs)
• Diuretics
• 6.12. Global Fast Melt Tablets Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cyclooxygenase-1 (COX-1) Inhibitors
• Cyclooxygenase-2 (COX-2) Inhibitors
• 6.13. Global Fast Melt Tablets Market, Sub-Segmentation Of Anti Allergy Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Leukotriene Receptor Antagonists
• Mast Cell Stabilizers
• Corticosteroids
• 6.14. Global Fast Melt Tablets Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Omeprazole
• Esomeprazole
• Lansoprazole
• Pantoprazole
• 6.15. Global Fast Melt Tablets Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiemetics
• Antidepressants
• Muscle Relaxants
• Analgesics

7. Fast Melt Tablets Market Regional And Country Analysis

• 7.1. Global Fast Melt Tablets Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Fast Melt Tablets Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fast Melt Tablets Market

• 8.1. Asia-Pacific Fast Melt Tablets Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fast Melt Tablets Market

• 9.1. China Fast Melt Tablets Market Overview
• 9.2. China Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fast Melt Tablets Market

• 10.1. India Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fast Melt Tablets Market

• 11.1. Japan Fast Melt Tablets Market Overview
• 11.2. Japan Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fast Melt Tablets Market

• 12.1. Australia Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fast Melt Tablets Market

• 13.1. Indonesia Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fast Melt Tablets Market

• 14.1. South Korea Fast Melt Tablets Market Overview
• 14.2. South Korea Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fast Melt Tablets Market

• 15.1. Western Europe Fast Melt Tablets Market Overview
• 15.2. Western Europe Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fast Melt Tablets Market

• 16.1. UK Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fast Melt Tablets Market

• 17.1. Germany Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fast Melt Tablets Market

• 18.1. France Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fast Melt Tablets Market

• 19.1. Italy Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fast Melt Tablets Market

• 20.1. Spain Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fast Melt Tablets Market

• 21.1. Eastern Europe Fast Melt Tablets Market Overview
• 21.2. Eastern Europe Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fast Melt Tablets Market

• 22.1. Russia Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fast Melt Tablets Market

• 23.1. North America Fast Melt Tablets Market Overview
• 23.2. North America Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fast Melt Tablets Market

• 24.1. USA Fast Melt Tablets Market Overview
• 24.2. USA Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fast Melt Tablets Market

• 25.1. Canada Fast Melt Tablets Market Overview
• 25.2. Canada Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fast Melt Tablets Market

• 26.1. South America Fast Melt Tablets Market Overview
• 26.2. South America Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fast Melt Tablets Market

• 27.1. Brazil Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fast Melt Tablets Market

• 28.1. Middle East Fast Melt Tablets Market Overview
• 28.2. Middle East Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fast Melt Tablets Market

• 29.1. Africa Fast Melt Tablets Market Overview
• 29.2. Africa Fast Melt Tablets Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Fast Melt Tablets Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Fast Melt Tablets Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fast Melt Tablets Market Competitive Landscape And Company Profiles

• 30.1. Fast Melt Tablets Market Competitive Landscape
• 30.2. Fast Melt Tablets Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Fuji Chemical Industries Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Fast Melt Tablets Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Ltd
• 31.2. Catalent Inc.
• 31.3. Aurobindo Pharma Limited
• 31.4. Glenmark Pharmaceuticals Ltd.
• 31.5. Torrent Pharmaceuticals Ltd.
• 31.6. Centrient Pharmaceuticals B.V.
• 31.7. Lannett Company Inc.
• 31.8. Unichem Laboratories Ltd.
• 31.9. SPI Pharma Inc.
• 31.10. Windmill Health Products LLC
• 31.11. The Procter & Gamble Company
• 31.12. Perrigo Company plc
• 31.13. Melt Pharmaceuticals Inc.
• 31.14. Imodium
• 31.15. Calpol

32. Global Fast Melt Tablets Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fast Melt Tablets Market

34. Recent Developments In The Fast Melt Tablets Market

35. Fast Melt Tablets Market High Potential Countries, Segments and Strategies

• 35.1 Fast Melt Tablets Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Fast Melt Tablets Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Fast Melt Tablets Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34850_Fast_Melt_Tablets_GMR_2025